Tirzepatide (Mounjaro) – GLP + GIP once weekly injection

Tirzepatide (Mounjaro) is a single molecule that activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. GLP-1 is known to regulate body weight via its actions in the central nervous system. Similarly, GIP receptors are found in areas of the CNS that may regulate body weight through appetite and food intake mechanisms.

Preclinical studies have also shown GIP receptors in areas of the brain known to act on appetite control centers, which may reduce caloric consumption

Click to Schedule Your Consultation!

Appetite Suppression & Decreased Food Intake

Weight Loss

Decreased Insulin Resistance

Tizepatide (Mounjaro) is a subcutaneous one weekly injection

Tirzepatide is a subcutaneous injection which is dosed once weekly. This medication is generally well-tolerated and can be dosed continuously without breaking treatment with no diminishing effects.

Side Effects & Contraindications

Everyone can have a different experience, but here are the most common side effects experienced by patients taking Tirzepatide: Nausea, Diarrhea, Decreased Appetite, Vomiting, Constipation, Indigestion, Stomach Pain.
In studies, most nausea, vomiting and diarrhea events occurred while the dose of Tirzepatide was being increased, and these events decreased over time.

Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.

Severe stomach problems. Stomach problems, sometimes severe, have been reported with Tirzepatide. Tell your healthcare provider if you have stomach problems that are severe or will not go away.

Contraindications: Do not use Tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC). Do not use Tirzepatide if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use Tirzepatide if you are allergic to it or any of the ingredients in Tirzepatide.

Schedule Appointment

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Stomach Pain